Syrma SGS Technology is an Electronics Manufacturing Services (EMS) company that's doing something uncommon in the sector — growing fast while expanding margins. Q3 FY26 delivered 43% revenue growth with EBITDA margins above 12%, and management used the word "confident" multiple times on a call where analysts actively tried to stress-test the numbers.

Headline Numbers — Q3 FY26

Metric Q3 FY26 Context
Revenue ₹1,274 cr +43% YoY
EBITDA ₹159 cr 12.6% margin — above guidance
PAT ₹110 cr +108% YoY
Exports ₹335 cr +66% YoY — growing faster than domestic
9M Revenue ₹3,380 cr +17% YoY
9M EBITDA ₹370 cr —
9M PAT ₹227 cr —
Order Book ₹6,400 cr Strong FY27 revenue coverage
Net Cash ₹404 cr (Cash ₹933 cr – Debt ₹529 cr)
FY26 EBITDA Target ₹500 cr+ Raised from ₹450 cr
FY27 Guidance 30% revenue + 30% EBITDA —

What Drove the Results

43% revenue growth is broad-based — automotive, industrial, and healthcare verticals all grew. The 9M trajectory tells the real story: Q1 was -19% YoY, Q2 recovered to +37%, Q3 hit +45%. Management expects Q4 to sustain this, supported by Elcome integration (₹100-120 crore contribution expected) and seasonally stronger healthcare demand.

Margins at 12.6% vs 8% guidance at year-start — this is the number analysts challenged most. Management's explanation is structural, not accidental:

  • Export mix is higher (25% of 9M revenue vs 22.5% last year) — exports carry better margins
  • Operating leverage: scaling from a ₹3,500 crore to ₹5,000 crore revenue base means fixed costs are absorbed over more revenue
  • Procurement efficiencies (~1% gross margin contribution)

Management explicitly said Q3 EBITDA includes ₹12 crore from the Elcome acquisition consolidation — excluding that, EBITDA was ₹147 crore at 11.5% margin. Still above guidance.

FY26 EBITDA target raised to ₹500 crore+ — up from the earlier ₹450 crore and represents ~58% growth over FY25. This is a guidance raise, not a revision of Q3 methodology.

Order book of ₹6,400 crore with net cash of ₹404 crore — the balance sheet supports ₹360-400 crore of PCB CapEx without financial stress.

The Elcome Acquisition and PCB Project

Two strategic investments that weren't just announced — they're executing:

Elcome acquisition (defence electronics): Integrated in Q3. Contributes ₹100-120 crore to Q4 revenue. Gives Syrma a defence electronics capability — circuit boards and systems for Indian defence programs. This is a meaningful diversification from commercial EMS.

PCB manufacturing project: ₹360-400 crore Phase 1 CapEx, Andhra Pradesh government support. PCBs are currently a large import category in India's electronics supply chain. Syrma owning PCB manufacturing addresses a key input cost and opens a new revenue stream. Management confirmed Phase 1 is on track.

What Management Said

On FY26 EBITDA confidence: "Confidence based on sequential improvement trend, Elcome contribution of ₹100-120 crore, and seasonally stronger healthcare. Reiterating ₹500 crore+ EBITDA." — Specific, not vague.

On US tariff uncertainty: "There is a cloud over the industry from US tariffs. We are monitoring actively. Our exposure is manageable but we won't pretend the uncertainty doesn't exist." — Unusual candour for a prepared-remarks tone.

On FY27 guidance: "30% revenue and 30% EBITDA growth for FY27. Backed by order book, PCB ramp, Elcome scale-up, and continued export growth supported by EU-India FTA." — Not aspirational. Each component has a specific driver.

Key Tailwinds and Risks

Tailwinds:

  • EU-India FTA signed — expected to boost electronics exports long-term
  • Government PLI schemes supporting EMS and PCB manufacturing
  • Elcome integration opening defence electronics as a new vertical
  • Increasing digitisation across automotive, healthcare, industrial sectors
  • Net cash position — balance sheet supports CapEx investment

Risks:

  • US tariff uncertainty — Syrma has some exposure to US-bound electronics supply chains
  • Working capital cycles in smart meters are long — management is selectively engaging with this segment
  • PCB project execution risk — ₹400 crore Phase 1 CapEx, new capability build

StockMirror AI Signal Summary

Based on StockMirror's analysis of the Syrma SGS Q3 FY26 earnings call:

  • Overall Sentiment: Good
  • Management Confidence: High
  • Prepared Remarks: Great — 45% revenue growth, 101% EBITDA growth, guidance raised
  • Q&A Tone: Neutral — analysts probed margin sustainability and tariff exposure; management answered directly without overselling

The Prepared Remarks / Q&A split (Great vs Neutral) is healthy — management was genuinely enthusiastic about results but appropriately measured on analyst questions about risks. No evasion detected.

For the full AI analysis of the Syrma SGS Q3 FY26 earnings call — all 13 sections including management commentary on every analyst question:

Syrma SGS Full Earnings Analysis → /SYRMA/earnings

Related Articles

Disclaimer: Data sourced from Syrma SGS Q3 FY26 earnings call transcript and BSE/NSE filings. Not financial advice.